PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The smell of Mom: Scientists find elusive trigger of first suckling in mice

The smell of Mom: Scientists find elusive trigger of first suckling in mice
2012-10-04
(Press-News.org) LA JOLLA, CA – A team led by biologists at The Scripps Research Institute has solved the long-standing scientific mystery of how mice first know to nurse or suckle.

This basic mammalian instinct, which could be a key to understanding instinctive behavior more generally, was thought to be triggered by a specific odor (pheromone) that all mouse mothers emit. But, as described online ahead of print by the journal Current Biology on October 4, 2012, the trigger in mice turns out to be a more complicated blend of nature and nurture: a signature mix of odors, unique for each mother, which her offspring learn.

"We set out to find a pheromone trigger, but were excited to find this alternative mechanism," said team leader Lisa Stowers, an associate professor at Scripps Research who was the senior investigator for the new study. "Compared to a pheromonal system, this mechanism would have been easier for animals to evolve."

Looking for the 'On Switch'

Suckling is the defining behavior in mammals, whose very name refers to the milk-making mammary glands of the breast. Most mammals are born knowing how to find their mother's nipples and drink, and would quickly perish if they didn't—making suckling an example of an instinctive or "innate" behavior hard-wired into the brain. "So far, little is known about how innate behaviors are coded in the brain, what triggers them and what represses them," said Stowers.

A first step in studying an innate behavior is to look for its initial trigger or "on switch," yet that can be like searching for a proverbial needle in a haystack. Even a very young animal is exposed to a vast complexity of sights, sounds, smells and other factors. Many of these may seem to be triggers for an innate behavior, but that may be only because the animal has learned to associate them with the behavior. Finding the essential trigger for the very first instance of an innate behavior—before it has ever been experienced or taught—is a painstaking process of elimination requiring an array of sophisticated laboratory methods.

Scientists had found evidence that the trigger for initial suckling in mice is mediated by the main olfactory epithelium (MOE)—the principal smell organ, located within the nasal passages. Without the MOE, newborn mice fail to suckle and die of dehydration. In the new study, Stowers and her colleagues, including postdoctoral researcher Darren W. Logan, who performed most of the experiments, set out to find the special MOE-sensed odor that triggers initial suckling.

Process of Elimination

Stowers's initial hypothesis was that the trigger was a pheromone, a chemical that is emitted by one animal and straightforwardly triggers a behavior or other response in another. In separate research, her laboratory had found several pheromones that activate other innate behaviors in mice. Moreover, an independent group of scientists had found that a specific, MOE-sensed pheromone in mother's milk serves as the trigger for initial suckling in the European Rabbit. Stowers and her colleagues expected to confirm that a similar chemical does the trick in mice.

The researchers began by subtracting certain maternal fluids from the environment of newborn mice, hoping thereby to see a delay or elimination of their first suckling, which would indicate that the subtracted fluid had contained the pheromonal trigger. The scientists eliminated maternal milk and saliva from the newborns' environment and still observed suckling behavior. That left the amniotic fluid of the womb as the source of the suckling trigger. Next the scientists fractionated the amniotic fluid, separating its chemicals into different molecular weight ranges, with the expectation that they would find the trigger in one of these smaller mixes and eventually isolate a single pheromone.

"It soon became clear that the trigger is not a classic pheromone," Stowers said. No single fractionated part of the amniotic fluid could trigger suckling on its own. Even more strikingly, when the researchers added other chemicals such as vanillin to samples of amniotic fluid, the altered amniotic fluid no longer triggered suckling in newborns—whereas a typical pheromone would still have worked under such circumstances. After further tests, Stowers and her colleagues were forced to conclude that there is no single chemical trigger that works for all newborn mice.

Surprising Results

Instead, the results indicated that the trigger for the first suckling in newborn mice is a blend of chemicals that is specific for each mouse mother. The brain of a mouse does not recognize this maternal "signature blend" automatically with neural circuits that are fully programmed by the mouse genome. It must learn the signature blend before it is able to suckle. In a narrow time window after birth, a re-exposure to this maternal odor mix triggers suckling. Thus, a behavior that appears completely innate is triggered by a mechanism that is partly learned.

The results suggest to Stowers and her colleagues that other seemingly innate behaviors in mammals may have learned triggers that make use of the versatile MOE. "This mechanism that we found is really just a twist on what the main olfactory system already does, which is to learn to recognize odors to guide an animal's behavior," Stowers said.

Stowers and her colleagues now hope to characterize the special, just-after-birth window of time within which the odor mix of a mother mouse triggers suckling in her newborns. "When we have a full understanding of the trigger mechanism, we'll use it to stimulate the relevant MOE sensory neurons in the lab," Stowers said. "We'll explore the connections those neurons make in the brain, and thus we'll be able to study how these circuits bring about this fundamental behavior."

The other contributors to the paper, "Learned recognition of maternal signature odors mediates the first suckling episode in mice," were Lisa J. Brunet and John Ngai from the University of California, Berkeley, William R. Webb of the Center for Mass Spectrometry at Scripps Research, and Tyler Cutforth of the University of California, Irvine. Darren W. Logan is now a Group Leader at the Wellcome Trust Sanger Institute in Cambridgeshire, UK.



INFORMATION:

The research was supported by NIH-NIDCD (R01 DC009413, R01 DC006885), the Skaggs Foundation at Scripps Research, and a grant from the Wellcome Trust (#098051).

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. Over the past decades, Scripps Research has developed a lengthy track record of major contributions to science and health, including laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. The institute employs about 3,000 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including three Nobel laureates—work toward their next discoveries. The institute's graduate program, which awards Ph.D. degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.


[Attachments] See images for this press release:
The smell of Mom: Scientists find elusive trigger of first suckling in mice

ELSE PRESS RELEASES FROM THIS DATE:

In cancer, an embryonic gene-silencing mechanism gone awry

2012-10-04
There are some genes that are only activated in the very first days of an embryo's existence. Once they have accomplished their task, they are shut down forever, unlike most of our genes, which remain active throughout our lives. EPFL scientists have unveiled part of this strange mechanism. The same process, accidentally initiated later in life, could be responsible for many kinds of cancer. The discovery is described in a recent article in the journal Cell Reports. The researchers identified a group of proteins that play a key role in this phenomenon. They bind to a ...

BWH researchers discover genetic risk for uterine fibroids

BWH researchers discover genetic risk for uterine fibroids
2012-10-04
BOSTON, MA—Uterine fibroids are the most common type of pelvic tumors in women and are the leading cause of hysterectomy in the United States. Researchers from Brigham and Women's Hospital (BWH) are the first to discover a genetic risk allele (an alternative form of a gene) for uterine fibroids in white women using an unbiased, genome-wide approach. This discovery will pave the way for new screening strategies and treatments for uterine fibroids. The study will be published online on October 4, 2012 in The American Journal of Human Genetics. The research team, led by ...

Study shows benefits, drawbacks, for women's incontinence treatments

2012-10-04
Oral medication for treating a type of incontinence in women is roughly as effective as Botox injections to the bladder, reported researchers who conducted a National Institutes of Health clinical trials network study, with each form of treatment having benefits and limitations. After six months, women in both treatment groups said that the average number of daily episodes had declined from about five per day to about 1-2 per day. In the study, the researchers compared the effectiveness of Botox injections to oral anticholinergic medications for treating urge urinary ...

Babies learn the smell of mum

2012-10-04
Researchers show for the first time that a mammal begins to suckle its mother's milk through a learned response built on learning her unique combination of smells. When it is born, the newborn is exposed to the smell of its mother's amniotic fluid and the baby then responds to those smells to feed. Prevailing thought has been that pheromones –chemicals that trigger an innate behaviour – drove the suckling response as an automatic behaviour. The new work determines that, in mice, the smells must be learned before the behaviour can occur. Suckling is a critical step for ...

New function of a protein involved in colon cancer is identified

2012-10-04
Researchers from IMIM, Hospital del Mar Medical Research Institute, have succeeded in determining the function of a new variant of enzyme IKKalpha (IKKα) to activate some of the genes taking part in the tumor progressions of colorectal cancer. In the future, this fact will make it possible to design new drugs that inhibit this enzyme specifically and are less toxic for the remaining body cells, hence improving the treatment for this disease. The study is the culmination of previous research by the IMIM Research Group on Stem Cells and Cancer that had proven the ...

Penn researchers create a universal map of vision in the human brain

2012-10-04
PHILADELPHIA - Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see. Their result can, among other things, guide efforts to restore vision using a neural prosthesis that stimulates the surface of the brain. The study appears in the latest issue of Current ...

Better battlefield triage, transport may raise severely wounded soldiers' survival rates

2012-10-04
CHICAGO—Wounded soldiers who sustained chest injuries in Operation Enduring Freedom (Afghanistan) and Operation Iraqi Freedom (Iraq) had higher mortality rates than soldiers in Korea and Vietnam, according to a military trauma study presented at the 2012 American College of Surgeons Annual Clinical Congress. However, better battlefield triage and transport may have meant that severely wounded soldiers whom would have been considered killed in action in previous conflicts are more likely to get sent to trauma centers in the United States sooner in their course of care, ...

Chewing ability linked to reduced dementia risk

2012-10-04
Can you bite into an apple? If so, you are more likely to maintain mental abilities, according to new research from Karolinska Institutet in Sweden. The population is ageing, and the older we become the more likely it is that we risk deterioration of our cognitive functions, such as memory, decision-making and problem solving. Research indicates several possible contributors to these changes, with several studies demonstrating an association between not having teeth and loss of cognitive function and a higher risk of dementia. One reason for this could be that few ...

No evidence for 30-nm chromatin fibers in the mouse genome

No evidence for 30-nm chromatin fibers in the mouse genome
2012-10-04
HEIDELBERG, 4 October 2012 – Scientists in Canada and the United States have used three-dimensional imaging techniques to settle a long-standing debate about how DNA and structural proteins are packaged into chromatin fibres. The researchers, whose findings are published in EMBO reports, reveal that the mouse genome consists of 10-nm chromatin fibres but did not find evidence for the wider 30-nm fibres that were previously thought to be important components of the DNA architecture. "DNA is an exceptionally long molecule that can reach several metres in length. This means ...

New gene test detects early mouth cancer risk

2012-10-04
Researchers from Queen Mary, University of London have developed a new gene test that can detect pre-cancerous cells in patients with benign-looking mouth lesions. The test could potentially allow at-risk patients to receive earlier treatment, significantly improving their chance of survival. The study, published online in the International Journal of Cancer, showed that the quantitative Malignancy Index Diagnostic System (qMIDS) test had a cancer detection rate of 91-94 per cent when used on more than 350 head and neck tissue specimens from 299 patients in the UK and ...

LAST 30 PRESS RELEASES:

Scientists uncover key to decoupling economic growth from pollution in developing countries

Frailty fuels gut imbalance and post-surgery gastrointestinal risks

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

[Press-News.org] The smell of Mom: Scientists find elusive trigger of first suckling in mice